CLASS II Food recall · Reported 20 Nov 2013 · FDA Enforcement Report

Klaire Labs Vital-Zymes complete recalled by ProThera

ProThera is recalling Klaire Labs Vital-Zymes complete. The recall was initiated on 10 Oct 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #'s 0613110, 0513156 and 0513157
Quantity recalled187,941 lot 0613110; 491.232 lot 0513156 and 504864 lot 0513157

Do not eat it. Return it to the store for a refund or throw it away. If you have symptoms after eating it, contact a doctor.

Recall details

Recall number
F-0160-2014
FDA event ID
66553
Recalling firm
ProThera, Reno, NV
Classification
Class II
Status
Terminated
Recall initiated
10 Oct 2013
FDA classified
12 Nov 2013
Reported
20 Nov 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Product category
Dietary Supplements

Timeline

10 Oct 2013Recall initiated by company
12 Nov 2013Classified by FDA+33 days
20 Nov 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.

Product as listed by the FDA

Klaire Labs Vital-Zymes complete; Comprehensive Enzyme Supplement; 120 Vegetarian tablets. UPC 790616310005 Manufactured by ProThera, Inc., , Klaire Labs is a division of ProThera Reno, NV 89521

Where it was distributed

US and Australia, Azerbaijan, Brazil, Canada, Germany, Great Britain, Hong Kong, Ireland (Eire, Japan, Malaysia, Malta, Mexico, New Zealand, Panama, Philippines, Russia, South Korea, Spain, Switzerland, Thailand.

Questions about this recall

Why was it recalled?

ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.

Which lots are affected?

Lot #'s 0613110, 0513156 and 0513157

Where was it sold?

US and Australia, Azerbaijan, Brazil, Canada, Germany, Great Britain, Hong Kong, Ireland (Eire, Japan, Malaysia, Malta, Mexico, New Zealand, Panama, Philippines, Russia, South Korea, Spain, Switzerland, Thailand.

What should I do if I have it?

Do not eat it. Return it to the store for a refund or throw it away. If you have symptoms after eating it, contact a doctor.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 66553

This product is part of a recall event; the main page for the event is Klaire Labs Interfase recalled by ProThera.

ReportedClassRecallCompanyReasonWhere
CLASS IIKlaire Labs Interfase recalled by ProTheraKlaire LabsProTheraPackaging DefectsNV
CLASS IIKlaire Labs Vital-Zymes Chewable recalled by ProTheraKlaire LabsProTheraOtherNV
CLASS IIKlaire Labs Interfase Plus recalled by ProTheraKlaire LabsProTheraOtherNV
CLASS IISerralase Enzyme Supplements recalled by ProTheraSerralase EnzymeProTheraPackaging DefectsNV

More recalls from ProThera

All 11

Other Dietary Supplements recalls

All 734